Evidence map›Paper›PMID 42786290›Full record

ArticleNature methods2026

ResolVI: addressing noise and bias in spatial transcriptomics.

Can Ergen, Nir Yosef

Abstract read
In one paragraph

Article in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Can ErgenCenter for Computational Biology, University of California, Berkeley, CA, USA. ergenbehr@gmail.com.ORCID http://orcid.org/0000-0002-3096-2927
Nir YosefSystem Immunology, Weizmann Institute of Science, Rehovot, Israel. nir.yosef@weizmann.ac.il.ORCID http://orcid.org/0000-0001-9004-1225

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) 448802458EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101089213Silicon Valley Community Foundation (SVCF) EOSS4-0000000121
6 · The paper itself

Abstract

Technologies for estimating RNA expression at high throughput, in intact tissue slices and with high spatial resolution (spatial transcriptomics) shed new light on how cells communicate and tissues function. A fundamental step in analyzing data generated by subcellular resolution spatial transcriptomics technologies is quantification, namely, segmenting the plane into regions, each approximating a cell, and then collating the molecules inside each region to estimate the cellular expression profile. Despite many advances in this area, a persistent problem is that of the incorrect assignment of molecules to cells, which limits many current applications to the level of a priori-defined cell subsets and complicates the discovery of novel cell states. Here we develop resolVI, a model that operates downstream of any segmentation algorithm to generate a probabilistic representation, correcting for the misassignment of molecules, as well as for batch effects and other nuisance factors. We demonstrate that resolVI improves our ability to distinguish between cell states, identify subtle expression changes in space and perform integrated analysis across datasets. ResolVI is available as open source software within scvi-tools.

Indexed as

Gene Expression ProfilingSoftwareSpatial TranscriptomicsTranscriptomeAlgorithmsAnimalsHumans

Identifiers

PMID42786290
PMCPMC13645626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.